| Conversations around Tiered Screening Webinar Series Part 1: History of Second-tier testing in Newborn Screening | Conversations around Tiered Screening Webinar Series Part 1: History of Second-tier testing in Newborn Screening | The Association of Public Health Laboratories (APHL) Newborn Screening Technical assistance and Evaluation Program (NewSTEPs) is pleased to announce the commencement of the Conversations around Tiered Screening Webinar Series on Thursday, August 13 at 200 pm ET. This four-part webinar series will provide considerations for selecting, designing, and implementing a tiered testing strategy and explore the implications of adopting various tiered testing strategies. These webinars, guided by APHL’s New Disorders Workgroup in collaboration with the Molecular Subcommittee, are open to all newborn screening stakeholders.
The initial webinar will provide a brief history of second-tier testing as it has been added throughout the years in newborn screening programs. Speakers will provide an overview of the history of second-tier screening methods for Congenital Hypothyroidism (CH), Galactosemia, various Hemoglobinopathies, Cystic Fibrosis (CF), Tyrosinemia type I, Congenital Adrenal Hyperplasia (CAH), Homocystinuria (HCY), certain Lysosomal Disorders (LSDs), and Spinal Muscular Atrophy (SMA). | 2020-08-13T18:00:00Z | 2020-08-13T19:00:00Z | https://aphl.zoom.us/meeting/register/tJ0pceiurD4tHNVOMFJCZYO2d9SKUVBVs3Yh, https://aphl.zoom.us/meeting/register/tJ0pceiurD4tHNVOMFJCZYO2d9SKUVBVs3Yh | |
| Conversations around Tiered Screening Webinar Series Part 2: What is the Role of the Newborn Screening Program Moving Forward with Tiered Testing | Conversations around Tiered Screening Webinar Series Part 2: What is the Role of the Newborn Screening Program Moving Forward with Tiered Testing | The Association of Public Health Laboratories (APHL) Newborn Screening Technical assistance and Evaluation Program (NewSTEPs) is pleased to announce the second webinar in the Conversations around Tiered Screening Webinar Series on Friday, August 28 at 200 pm ET. This four-part webinar series will provide considerations for selecting, designing, and implementing a tiered testing strategy and explore the implications of adopting various tiered testing strategies. These webinars, guided by APHL’s New Disorders Workgroup in collaboration with the Molecular Subcommittee, are open to all newborn screening stakeholders.
This webinar will explore the role of the newborn screening program to provide tiered testing, as more disorders are added to the Recommended Uniform Screening Panel (RUSP). Speakers will examine the future application and feasibility of tiered testing for newborn screening disorders and the potential consequences. | 2020-08-28T18:00:00Z | 2020-08-28T19:00:00Z | https://aphl.zoom.us/meeting/register/tJAsdOyspzIrGdy9_Ck-naNJ4PQ485vT4zZN, https://aphl.zoom.us/meeting/register/tJAsdOyspzIrGdy9_Ck-naNJ4PQ485vT4zZN | |
| Biochemical Second-tier testing and Molecular Second- and third-tier testing Options and Consideration | Biochemical Second-tier testing and Molecular Second- and third-tier testing Options and Consideration | The Association of Public Health Laboratories (APHL) Newborn Screening Technical assistance and Evaluation Program (NewSTEPs) is pleased to announce the third webinar in the Conversations around Tiered Screening Webinar Series on Thursday, September 3, 2020 at 200 pm ET. This four-part webinar series will provide considerations for selecting, designing, and implementing a tiered testing strategy and explore the implications of adopting various tiered testing strategies. These webinars, guided by APHL’s New Disorders Workgroup in collaboration with the Molecular Subcommittee, are open to all newborn screening stakeholders.
This webinar will provide an overview of biochemical second-tier testing and molecular second- and third-tier testing options using CAH, HCY, MPS I, X-ALD, Pompe, VLCAD, and SCID as examples. Speakers will discuss the factors to consider when adding biochemical second-tier testing and molecular second- and third-tier testing, and the pros and cons of each testing option. | 2020-09-03T18:00:00Z | 2020-09-03T19:30:00Z | https://aphl.zoom.us/meeting/register/tJYkc-2urzwpE93vNAdBzLnDKCtDaopm5J8l, https://aphl.zoom.us/meeting/register/tJYkc-2urzwpE93vNAdBzLnDKCtDaopm5J8l | |
| Designing a Tiered Testing Strategy | Designing a Tiered Testing Strategy | The Association of Public Health Laboratories (APHL) Newborn Screening Technical assistance and Evaluation Program (NewSTEPs) is pleased to announce the last webinar in the Conversations around Tiered Screening Webinar Series on Thursday, September 11, 2020 at 200 pm ET. This four-part webinar series will provide considerations for selecting, designing, and implementing a tiered testing strategy and explore the implications of adopting various tiered testing strategies. These webinars, guided by APHL’s New Disorders Workgroup in collaboration with the Molecular Subcommittee, are open to all newborn screening stakeholders.
In this webinar, participants will learn how to design a tiered testing strategy. Speakers will discuss testing strategies for performing in-house testing and contracting out. | 2020-09-11T18:00:00Z | 2020-09-11T19:00:00Z | https://aphl.zoom.us/meeting/register/tJwrf-mhqDgtGd0QFN40mf8eucyzkaOFFoI7, https://aphl.zoom.us/meeting/register/tJwrf-mhqDgtGd0QFN40mf8eucyzkaOFFoI7 | |